Multinationals on China|Edwards Lifesciences Greater China: Innovating for Chinese patients

2023年12月30日 11:38   21世纪经济报道 21财经APP   李依农,季媛媛,
播放 暂停
进入全屏 退出全屏
00:00 00:00
重播 刷新试试

南方财经全媒体记者 李依农 上海报道

George Ye, General Manager of Edwards Lifesciences Greater China, highlighted in an interview with SFC journalist that China has emerged as the world's second-largest economy and the second-largest global medical device market over the past decades, achieving remarkable success. Ye emphasized, "The benefits reaped by Edwards Lifesciences from China's reform and opening-up are considerable."

Looking forward, Ye pointed out that China will encounter challenges in resource balancing. Specifically, it needs to prioritize cost-effective treatments to meet the demands of its extensive medical market while introducing innovative drugs and technologies to deliver high-quality medical services to all domestic patients. Despite these challenges, Ye expressed confidence that this issue will be successfully addressed.

策划:于晓娜    

监制:施诗

责任编辑:和佳

记者: 季媛媛 李依农 

制作:李群 

新媒体统筹:丁青云 曾婷芳 赖禧 黄达迅

海外运营监制: 黄燕淑

海外运营内容统筹: 黄子豪 

海外运营编辑:庄欢 吴婉婕 龙李华 张伟韬

出品:南方财经全媒体集团

关注我们

站长统计